Poland R E, McCracken J T, Lutchmansingh P, Tondo L
Department of Psychiatry, Harbor-UCLA Medical Center, Torrance.
Pharmacopsychiatry. 1993 May;26(3):79-83. doi: 10.1055/s-2007-1014347.
Dexamethasone (DEX) (0.5 mg, P.O.) and placebo were administered at 2300 h in randomized design to 19 patients with major depression and the effects on the sleep electroencephalogram (EEG) were studied. In addition, the thyroid stimulating hormone (TSH) response to thyrotropin releasing hormone (TRH) and basal plasma cortisol concentrations were assessed the following morning. DEX did not affect sleep architecture or continuity variables, including rapid eye movement (REM) latency, REM activity and REM density. Similarly, DEX did not significantly influence the TSH response to TRH (delta max TSH). In contrast, plasma cortisol concentrations were significantly suppressed by DEX. The results indicate that, as opposed to higher dosages of glucocorticoids, 0.5 mg DEX had minimal effects on the sleep EEG or delta max TSH in depressed patients.
采用随机设计,于23:00给19例重度抑郁症患者口服0.5mg地塞米松(DEX)和安慰剂,研究其对睡眠脑电图(EEG)的影响。此外,于次日上午评估促甲状腺激素(TSH)对促甲状腺激素释放激素(TRH)的反应以及基础血浆皮质醇浓度。DEX不影响睡眠结构或连续性变量,包括快速眼动(REM)潜伏期、REM活动和REM密度。同样,DEX对TSH对TRH的反应(最大TSH变化量)也无显著影响。相反,DEX可显著抑制血浆皮质醇浓度。结果表明,与较高剂量的糖皮质激素不同,0.5mg DEX对抑郁症患者的睡眠EEG或最大TSH变化量影响极小。